drug quality control
WHO Warns India Must Strengthen Regulations to Prevent Toxic Cough Syrup Deaths
Oct 21, 2025 08:21 pm CST
Despite some regulatory improvements, India still faces significant challenges in preventing toxic cough syrup sales, according to the WHO. Following the deaths of 24 children linked to contaminated medicine containing dangerous levels of diethylene glycol, officials highlight the need for comprehensive testing requirements for both exported and domestically sold pharmaceutical products.
Worms Found in Antibiotic Syrup at Madhya Pradesh Government Hospital Prompts Investigation
Oct 16, 2025 04:42 pm CST
Following child deaths from toxic cough syrup in Madhya Pradesh, a government hospital in Gwalior faces allegations of worm-contaminated antibiotic medicine. Officials have sealed the entire Azithromycin stock and sent samples for laboratory testing, highlighting growing concerns about pharmaceutical safety standards in India's healthcare system.
Coldrif Cough Syrup Tragedy: 20 Children Dead as Sresan Pharma Owner Faces Police Custody
Oct 11, 2025 07:16 am CST
The owner of Sresan Pharma, Ranganathan, has been remanded to 10-day police custody following the deaths of 20 children across three districts in Madhya Pradesh allegedly linked to Coldrif cough syrup. As investigations intensify, the DCGI has issued nationwide directives for stricter pharmaceutical testing protocols while local chemists protest through an indefinite strike.
India's Drug Regulator Issues Critical Advisory Following Fatal Cough Syrup Contamination Cases
Oct 09, 2025 12:51 am CST
India's drug regulator has issued an urgent advisory highlighting serious lapses in pharmaceutical manufacturing practices after multiple child deaths linked to contaminated cough syrups. Inspections revealed manufacturers failing to test raw materials and finished products as required by law, prompting increased regulatory scrutiny across states and renewed concerns about India's pharmaceutical quality control systems.
FAIMA Urges Health Ministry to Form Central Committee to Investigate Fatal Contaminated Cough Syrup Cases
Oct 08, 2025 09:07 pm CST
The Federation of All India Medical Association (FAIMA) has called for a central investigation committee to examine the deaths of over 20 children in Madhya Pradesh and Rajasthan linked to contaminated Coldrif cough syrup. The medical body emphasized the need for nationwide testing of pediatric medications, improved regulatory coordination, and protection of physicians from premature blame while ensuring pharmaceutical safety standards are enforced.
Deadly Contamination: How Substandard Manufacturing Led to Fatal Cough Syrup Poisoning of 16 Children
Oct 06, 2025 10:50 pm CST
An investigation into the fatal Coldrif cough syrup reveals shocking manufacturing conditions at Sresan Pharmaceuticals, where industrial chemicals replaced pharmaceutical-grade ingredients, leading to 16 children's deaths in Madhya Pradesh. Inspectors found 39 critical and 325 major violations, including untested raw materials, untrained staff, and toxic levels of diethylene glycol—nearly 500 times above permissible limits.
Deadly Cough Syrup Claims 16 Children: Madhya Pradesh Government Takes Swift Action Against Officials
Oct 06, 2025 08:52 pm CST
Following a tragic incident where 16 children died after consuming Coldrif cough syrup in Chhindwara, the Madhya Pradesh government has implemented immediate measures including suspending key FDA officials, banning the medication, and launching a door-to-door recovery campaign. Chief Minister Mohan Yadav has ordered comprehensive quality checks on all medications while facing mounting political pressure from opposition leaders demanding accountability and compensation for affected families.
India's Health Ministry Responds to Child Deaths from Contaminated Cough Syrup: Urgent Regulatory Actions and Safety Measures
Oct 05, 2025 11:15 pm CST
Following the deaths of 14 children in Madhya Pradesh and Rajasthan linked to contaminated cough syrup, India's Health Ministry has implemented emergency measures to enhance pharmaceutical oversight. The tainted Coldrif cough syrup contained diethylene glycol, prompting stricter enforcement of manufacturing standards, rational prescription practices for pediatric medications, and improved surveillance systems. Health authorities are warning of criminal negligence in pharmaceutical production while emphasizing that most childhood coughs don't require medication.
Dangerous Diethylene Glycol Contamination Found in 'Coldrif' Cough Syrup: Health Ministry Confirms Safety Risk
Oct 04, 2025 05:44 pm CST
The Health Ministry has confirmed that 'Coldrif' cough syrup manufactured by Sresan Pharma in Tamil Nadu contains diethylene glycol (DEG) exceeding safe limits. This industrial solvent can cause severe kidney damage, liver failure, and death, particularly in children. Both Tamil Nadu and Madhya Pradesh have banned the product while authorities conduct comprehensive investigations at 19 manufacturing sites across six states.